210 related articles for article (PubMed ID: 26520098)
1. Angiosuppressive properties of marine-derived compounds-a mini review.
Yue PY; Leung HM; Li AJ; Chan TN; Lum TS; Chung YL; Sung YH; Wong MH; Leung KS; Zeng EY
Environ Sci Pollut Res Int; 2017 Apr; 24(10):8990-9001. PubMed ID: 26520098
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs.
Rüegg C; Hasmim M; Lejeune FJ; Alghisi GC
Biochim Biophys Acta; 2006 Apr; 1765(2):155-77. PubMed ID: 16263219
[TBL] [Abstract][Full Text] [Related]
3. Marine-derived angiogenesis inhibitors for cancer therapy.
Wang YQ; Miao ZH
Mar Drugs; 2013 Mar; 11(3):903-33. PubMed ID: 23502698
[TBL] [Abstract][Full Text] [Related]
4. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effects of marine sponge derived compounds on cancer.
Senthilkumar K; Venkatesan J; Manivasagan P; Kim SK
Environ Toxicol Pharmacol; 2013 Nov; 36(3):1097-108. PubMed ID: 24148290
[TBL] [Abstract][Full Text] [Related]
6. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.
Konson A; Pradeep S; Seger R
Cancer Res; 2010 Aug; 70(15):6247-57. PubMed ID: 20610633
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases.
Jeong HS; Jones D; Liao S; Wattson DA; Cui CH; Duda DG; Willett CG; Jain RK; Padera TP
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063793
[TBL] [Abstract][Full Text] [Related]
8. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
9. Current strategies and future directions of antiangiogenic tumor therapy.
Zhang ZL; Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
Sessa C; Guibal A; Del Conte G; Rüegg C
Nat Clin Pract Oncol; 2008 Jul; 5(7):378-91. PubMed ID: 18560389
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
12. A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compounds.
Abbaszadeh H; Keikhaei B; Mottaghi S
Phytother Res; 2019 Aug; 33(8):2002-2014. PubMed ID: 31373113
[TBL] [Abstract][Full Text] [Related]
13. [Tumor angiogenesis: new approaches to cancer therapy].
Marmé D
Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
15. Clinical research on antiangiogenic therapy.
Kuiper RA; Schellens JH; Blijham GH; Beijnen JH; Voest EE
Pharmacol Res; 1998 Jan; 37(1):1-16. PubMed ID: 9503474
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
Ebrahim HY; El Sayed KA
Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26978377
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies.
Reinacher-Schick A; Pohl M; Schmiegel W
Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):250-67. PubMed ID: 18382435
[TBL] [Abstract][Full Text] [Related]
20. [Potential role of antiangiogenic treatment in neuroblastoma].
Taylor M; Geoerger B; Lagodny J; Farace F; Vassal G; Rössler J
Arch Pediatr; 2009 May; 16(5):457-67. PubMed ID: 19299115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
